During the past decade, CHOC PSF, AMC, Division of Allergy, Asthma & Immunology conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "CHOC PSF, AMC, Division of Allergy, Asthma & Immunology" #1 collaborator was "Cephalon" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "CHOC PSF, AMC, Division of Allergy, Asthma & Immunology" are "Perennial Allergic Rhinitis" (3 trials), "Eosinophilic Esophagitis" (2 trials), "Allergic Rhinitis" (1 trials), "Asthma" (1 trials) and "Chronic Sinusitis" (1 trials). Many other conditions were trialed in "CHOC PSF, AMC, Division of Allergy, Asthma & Immunology" in a lesser frequency.

Most popular intervention types in "CHOC PSF, AMC, Division of Allergy, Asthma & Immunology" are "Drug" (7 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Ciclesonide HFA 160 mcg" (1 trials), "Ciclesonide HFA 80 mcg" (1 trials), "Ciclesonide nasal aerosol 37 mcg" (1 trials) and "R940343 1mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "CHOC PSF, AMC, Division of Allergy, Asthma & Immunology" are 8 trials for "All" genders.

Currently, there are NaN active trials in "CHOC PSF, AMC, Division of Allergy, Asthma & Immunology". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in CHOC PSF, AMC, Division of Allergy, Asthma & Immunology, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in CHOC PSF, AMC, Division of Allergy, Asthma & Immunology, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".